Search research articles
Contact Us
Filters
Showing results (101-110 of 143) with videos related to
Page
of 15
Sort By:
Cancers
|
August 19, 2020
Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study
Isabelle Mahé, Ludovic Plaisance, Céline Chapelle, et al.
Clinical Cardiology
|
July 18, 2019
EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non-valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study
Fabien Picard, Eric Van Ganse, Gregory Ducrocq, et al.
The American Journal of Medicine
|
February 8, 2005
Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen
Virginie Siguret, Isabelle Gouin, Matthieu Debray, et al.
Thrombosis Research
|
March 18, 2020
Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurely
José A Nieto, Damian Mora, Behnood Bikdeli, et al.
Thrombosis Research
|
December 9, 2023
Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism
José Antonio Rueda-Camino, Raquel Barba, Sonia Otálora, et al.
Stroke
|
June 17, 2020
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study
Eric Van Ganse, Nicolas Danchin, Isabelle Mahé, et al.
Thrombosis and Haemostasis
|
September 16, 2021
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer
Giancarlo Agnelli, Andrés Muñoz, Laura Franco, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 28, 2022
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France
Manon Belhassen, Olivier Hanon, Philippe Gabriel Steg, et al.
Thrombosis Research
|
April 16, 2018
Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study
Nick van Es, Yohei Hisada, Marcello Di Nisio, et al.
European Heart Journal
|
May 20, 2025
Acute pulmonary embolism: a multimarker calculator to predict short-term outcomes
David Jiménez, Álvaro Dubois-Silva, Pablo Demelo-Rodríguez, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 143) with videos related to
Sort By:
Page
of 15
Cancers
|
August 19, 2020
Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study
Isabelle Mahé, Ludovic Plaisance, Céline Chapelle, et al.
Clinical Cardiology
|
July 18, 2019
EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non-valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study
Fabien Picard, Eric Van Ganse, Gregory Ducrocq, et al.
The American Journal of Medicine
|
February 8, 2005
Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen
Virginie Siguret, Isabelle Gouin, Matthieu Debray, et al.
Thrombosis Research
|
March 18, 2020
Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurely
José A Nieto, Damian Mora, Behnood Bikdeli, et al.
Thrombosis Research
|
December 9, 2023
Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism
José Antonio Rueda-Camino, Raquel Barba, Sonia Otálora, et al.
Stroke
|
June 17, 2020
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study
Eric Van Ganse, Nicolas Danchin, Isabelle Mahé, et al.
Thrombosis and Haemostasis
|
September 16, 2021
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer
Giancarlo Agnelli, Andrés Muñoz, Laura Franco, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 28, 2022
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France
Manon Belhassen, Olivier Hanon, Philippe Gabriel Steg, et al.
Thrombosis Research
|
April 16, 2018
Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study
Nick van Es, Yohei Hisada, Marcello Di Nisio, et al.
European Heart Journal
|
May 20, 2025
Acute pulmonary embolism: a multimarker calculator to predict short-term outcomes
David Jiménez, Álvaro Dubois-Silva, Pablo Demelo-Rodríguez, et al.
Page
of 15